Daiichi Sankyo Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DAIICHI SANKYO INC, and when can generic versions of DAIICHI SANKYO INC drugs launch?
DAIICHI SANKYO INC has six approved drugs.
There are seventeen US patents protecting DAIICHI SANKYO INC drugs.
There are two hundred and ninety-three patent family members on DAIICHI SANKYO INC drugs in forty-five countries and twenty-three supplementary protection certificates in fifteen countries.
Summary for Daiichi Sankyo Inc
International Patents: | 293 |
US Patents: | 17 |
Tradenames: | 6 |
Ingredients: | 6 |
NDAs: | 6 |
Drugs and US Patents for Daiichi Sankyo Inc
Expired US Patents for Daiichi Sankyo Inc
Paragraph IV (Patent) Challenges for DAIICHI SANKYO INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Powder for Oral Suspension | 1.875 g/Packet and 3.75 g/Packet | ➤ Subscribe | 2010-04-09 |
➤ Subscribe | Tablets | 15 mg, 30 mg, 60 mg and 100 mg | ➤ Subscribe | 2019-01-28 |
➤ Subscribe | Tablets | 15 mg, 30 mg and 60 mg | ➤ Subscribe | 2019-01-28 |
➤ Subscribe | Tablets | 625 mg | ➤ Subscribe | 2009-07-01 |
➤ Subscribe | Capsules | 30 mg | ➤ Subscribe | 2009-02-27 |
➤ Subscribe | Tablets | 5 mg and 10 mg | ➤ Subscribe | 2013-07-10 |
International Patents for Daiichi Sankyo Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2451605 | See Plans and Pricing |
Mexico | 336789 | See Plans and Pricing |
Croatia | P20201383 | See Plans and Pricing |
Spain | 2304437 | See Plans and Pricing |
Japan | 5919253 | See Plans and Pricing |
South Africa | 200906182 | See Plans and Pricing |
Australia | 2008286914 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Daiichi Sankyo Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0542411 | SPC/GB09/032 | United Kingdom | See Plans and Pricing | PRODUCT NAME: PRASUGREL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/08/503/001 20090225; UK EU/1/08/503/002 20090225; UK EU/1/08/503/003 20090225; UK EU/1/08/503/004 20090225 |
1405852 | 15C0068 | France | See Plans and Pricing | PRODUCT NAME: EDOXABAN,UN SEL,SOLVATE OU N-OXYDE DE CELUI-CI,EN PARTICULIER L'EDOXABAN TOSYLATE; REGISTRATION NO/DATE: EU/1/15/993 20150619 |
2140867 | PA2018005,C2140867 | Lithuania | See Plans and Pricing | PRODUCT NAME: EDOKSABANAS, JO FARMACINIU POZIURIU PRIIMTINA DRUSKA, ARBA BET KURIO IS JU HIDRATAS, YPAC EDOKSABANO P-TOLUENSULFONATO MONOHIDRATAS; REGISTRATION NO/DATE: EU/1/15/993/001-028 20150619 |
0764174 | SPC/GB04/031 | United Kingdom | See Plans and Pricing | PRODUCT NAME: COLESEVELAM HYDROCHLORIDE; REGISTERED: UK EU/1/03/268/001-003 20040310 |
0764174 | C300159 | Netherlands | See Plans and Pricing | PRODUCT NAME: COLESEVELAM, DESGEWENST IN DE VORM VAN EEN; REGISTRATION NO/DATE: EU/1/03/268/001 20040310 |
1405852 | C01405852/01 | Switzerland | See Plans and Pricing | PRODUCT NAME: EDOXABAN; REGISTRATION NO/DATE: SWISSMEDIC 65149 31.03.2015 |
0542411 | C300397 | Netherlands | See Plans and Pricing | PRODUCT NAME: PRASUGREL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/08/503/001-014 20090225 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.